Nov 08, 2016 at 08:47 | Source: Moneycontrol.com
Nomura has a buy rating on ICICI with target price at Rs 325 per share as watchlist resolution was on expected lines in Q2.
Nov 07, 2016 at 08:33 | Source: Moneycontrol.com
Bank of America Merrill Lynch maintains buy on Lupin with regulatory overhang over valuations should recede post Goa Establishment Inspection Report (EIR). Goa plant accounts for over 50 percent of current supplies to US. It believes the stock should re-rate driven by near-term catalysts and due to faster ramp-up in Gavis portfolio.
Nov 04, 2016 at 15:44 | Source: PTI
The company had posted a net profit of Rs 87.48 crore in the corresponding quarter of previous fiscal, Gujarat Pipavav Port Ltd said in a filing to BSE.
Nov 04, 2016 at 14:18 | Source: Moneycontrol.com
Gujarat Pipavav Port Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 04, 2016 have declared payment of Interim Dividend of Rs. 2 per share for the current financial year 2016-17, on the Companys outstanding Equity Share Capital.
Nov 04, 2016 at 07:53 | Source: CNBC-TV18
Shahina Mukadam, Independent Market Expert suggests buying Lovable Lingerie with a target of Rs 298.
Oct 28, 2016 at 10:38 | Source: Moneycontrol.com
Gujarat Pipavav Port Ltd has informed BSE that the Companys Board Meeting is being held on November 04, 2016, to consider Unaudited Financial Results for the Quarter and Half year ended September 30, 2016.
Oct 18, 2016 at 13:43 | Source: CNBC-TV18
Here are a few top buzzing midcap stocks picked up by CNBC-TV18's analysts in trade today. We have - Aurobindo Pharma, Arvind, Shriram EPC, PNB, ICICI Bank, Gujarat Pipavav, Zensar, Aarti Drugs, Aarti Industries, and Indian Hume.
Oct 18, 2016 at 11:35 | Source: Moneycontrol.com
Credit Suisse has downgraded Gujarat Pipavav Port to underperform and also slashed target price to Rs 155 per share from Rs 195, citing lacklustre container trade data in Q2 and increase in risks to business.
Oct 18, 2016 at 09:15 | Source: Moneycontrol.com
CLSA maintains outperform rating on UltraTech Cement and raised target price to Rs 4425 per share from Rs 3900 per share as Q2 results ahead of estimate. It says demand pick-up and better cement pricing are key potential earnings growth drivers.
Oct 14, 2016 at 18:16 | Source: Moneycontrol.com
Net Sales are expected to increase by 7.1 percent Q-o-Q (up 20.1 percent Y-o-Y) to Rs 179 crore, according to Kotak Securities.